Citigroup’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Sell |
21,567
-12,602
| -37% | -$274K | ﹤0.01% | 2967 |
|
|
2025
Q1 | $632K | Buy |
34,169
+48
| +0.1% | +$888 | ﹤0.01% | 2822 |
|
|
2024
Q4 | $909K | Buy |
34,121
+13,721
| +67% | +$366K | ﹤0.01% | 2652 |
|
|
2024
Q3 | $479K | Buy |
20,400
+18,237
| +843% | +$429K | ﹤0.01% | 3016 |
|
|
2024
Q2 | $40.1K | Buy |
2,163
+422
| +24% | +$7.83K | ﹤0.01% | 3980 |
|
|
2024
Q1 | $31.1K | Buy |
+1,741
| New | +$31.1K | ﹤0.01% | 4134 |
|